AlloVir, Inc. (ALVR)

NASDAQ: ALVR · Real-Time Price · USD

0.570

+0.011 (1.93%)

At close: Nov 20, 2024, 4:00 PM

0.569

-0.001 (-0.19%)

After-hours: Nov 20, 2024, 4:04 PM EST

AlloVir Employees

AlloVir had 112 employees as of December 31, 2023. The number of employees increased by 6 or 5.66% compared to the previous year.

Employees

112

Change (1Y)

6

Growth (1Y)

5.66%

Revenue / Employee

n/a

Profits / Employee

-$894,616

Market Cap

65.16M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	112	6	5.66%
Dec 31, 2022	106	-1	-0.93%
Dec 31, 2021	107	54	101.89%
Dec 31, 2020	53	-	-

Related Stocks

Company Name	Employees
bluebird bio	375
Metagenomi	236
Atara Biotherapeutics	225
Boundless Bio	72
ALX Oncology Holdings	72
InspireMD	66
Cue Biopharma	53

Employee Rankings

ALVR News

11 days ago - ALLOVIR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AlloVir, Inc. - ALVR - Business Wire
11 days ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EMKR and ALVR on Behalf of Shareholders - GlobeNewsWire
13 days ago - AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina - GlobeNewsWire
2 months ago - Kuehn Law Encourages Investors of AlloVir, Inc. to Contact Law Firm - GlobeNewsWire
8 months ago - FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire
8 months ago - FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire
9 months ago - MARCH 19 FINAL DEADLINE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire
9 months ago - INVESTOR DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire